The samples were derived from cirrhotic (e.g., biliary atresia, PFIC II, autoimmune hepatitis) and non-cirrhotic (e.g., Maple syrup urine disease, ornithine transcarbamylase deficiency) livers. This evidence concerns the gene OTC and autoimmune hepatitis.